Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Suffix Smackdown: Gottlieb Calls Issue 'Red Herring' For Biosimilars

Jul 19 2018

• By Derrick Gingery

the word suffix on cubes

Related Content

USP Backs Down From Biologic Monograph Naming Plan Amid US FDA Objections

May 01 2018

Biologics Naming: US FDA Ponders How To Put New System In Place, While WHO Puts Hold On Pilot Study

Oct 27 2017

From Random To Meaningful: The Evolution Of Zarxio’s Suffix

Apr 27 2015

First Three Novel Biologic Suffixes Came Courtesy Of US FDA, Not Sponsors

Jan 27 2018

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 10 2017

Biological Product Suffix Submissions Limited To 10 Candidates By US FDA

Jan 16 2017

Industry May Like FDA's Biosimilar Guidance Withdrawal, But Not The New Information Vacuum

Jun 22 2018

FDA’s Burden Estimate On Biologic Naming Ignores Downstream Costs, Critics Say

Feb 16 2017

With Biosimilar Statistical Guidance Withdrawn, Expect Sponsor-Specific Advice, FDA's Christl Says

Jun 26 2018

Related Companies

Novartis AG

Genentech, Inc.

Ultragenyx Pharmaceutical Inc.

Spark Therapeutics, Inc.

Additional Topics

United States Biosimilars Biologics Regulation FDA BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.